Disease Info Card

Klippel-trenaunay-weber Syndrome

Information about Klippel-trenaunay-weber Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Klippel-trenaunay-weber Syndrome

Most recent studies have shown that Klippel-trenaunay-weber Syndrome shares some biological mechanisms with angiodysplasia, angiomatosis, arteriovenous-fistula, arteriovenous-malformation, congenital-abnormality, congenital-hemihypertrophy, congenital-vascular-anomaly, edema, hemangioma, hemorrhage, hypertrophy, melanocytic-nevus, neoplasms, neurocutaneous-syndromes, pathologic-fistula, port-wine-stain, skin-neoplasms, sturge-weber-syndrome, varicosity, vascular-anomaly.

Among the many pathways, these few ones have gauged particular interests from scientists studying Klippel-trenaunay-weber Syndrome, and have been seen in publications frequently: Anaphylaxis, Angiogenesis, Blood Coagulation, Cell Migration, Cell Proliferation, Coagulation, Fertilization, Fibrinolysis, Hemostasis, Localization, Lymphangiogenesis, Myelination, Pathogenesis, Pigmentation, Reflex, Tooth Eruption, Translation, Transposition, Vasculogenesis, Wound Healing

Quite a number of genes have been found to play important roles in Klippel-trenaunay-weber Syndrome, such as ACVRL1, AGGF1, BLOC1S2, GLA, GLMN, GNAI1, IGF2, IKBKG, KRIT1, LIFR, PDCD10, PNPLA6, PPFIBP1, RASA1, SYNGAP1, TEK, TNFSF12, VEGFA, ZACN. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.